Diagnosing Metal Hypersensitivity: Lymphocyte Proliferation Testing

Metal hypersensitivity is a cell-mediated immune response that can lead to various diseases, including the granulomatous lung disease called Chronic Beryllium Disease. Hypersensitivity to metals also is increasingly recognized as one of the causes of joint replacement failure.

 

More Than Two Decades of Experience

National Jewish Health® Advanced Diagnostic Laboratories has more than two decades of experience in developing and performing Lymphocyte Proliferation Tests (LPT) to measure cell-mediated immune response to metals.

  • Developed the first diagnostic blood test for beryllium sensitization called the Beryllium Lymphocyte Proliferation Test (BeLPT) in the 1990s

  • Performs more than 12,000 BeLPTs annually and is the leading beryllium sensitization testing laboratory in the United States

  • Introduced a nickel lymphocyte proliferation test (NiLPT) to detect nickel sensitization in 2012

Our hypersensitivity assays are developed collaboratively with National Jewish Health physicians, supported by research publications and performed in our CLIA-certified lab.

 

Lymphocyte Proliferation Test: Marker of Antigen Specific T cell Reaction

The lymphocyte proliferation test (LPT) is an in vitro test that measures the antigen-specific T cell response to a suspected antigen or metal in culture. LPTs can be performed alone or in conjunction with skin patch testing to demonstrate allergic or hypersensitivity responses.

 

Metal Hypersensitivity Diagnostic Tests

View Advanced Diagnostic Labs Test Catalog

 

Metal Hypersensitivity Testing Services

  • Custom lymphocyte proliferation assay development and validation

Request Information


Clinical Trials

For more than 100 years, National Jewish Health has been committed to finding new treatments and cures for diseases. Search our clinical trials.

Reasons to Visit National Jewish Health

  • The leading respiratory hospital in the nation and the only one devoted fully to the treatment of respiratory and related illnesses
  • Ranked as one of the top two hospitals in pulmonology every year since U.S. News & World Report included this category in its annual “Best Hospitals” survey
  • Ranked in the top 1 percent of hospitals in the nation by HCAHPS
  • Physicians frequently recognized as among the best in the nation by multiple services, including Best Doctors in America and Castle Connolly
  • Among the top 8 percent of organizations funded for research by the NIH, providing patients access to the latest clinical trials
  • 119 -year history of focus on care, research and education serving thousands of patients with lung, heart, immune and related disorders